New £50 million centre aims to shake up clinical trials in the UK

A new £50 million initiative aims to cut the length of time novel medicines spend in clinical trials, enabling patients to benefit from new treatments much sooner.

The UK’s Medical Research Council Centre of Research Excellence in Clinical Trial Innovation (MRC CoRE CTI), which is being set up in partnership with the National Institute for Health and Care Research, will receive £50 million over 14 years with the ambition of transforming the clinical trial landscape. The leadership group for MRC CoRE includes researchers from six UK universities: University College London, London School of Hygiene & Tropical Medicine, University of Cambridge, University of Edinburgh, University of Birmingham and Newcastle University.